Compare ABN Assistant vs. Carevive

Medical necessity denials represent a significant financial burden for healthcare providers, incurring costs that can reach into the millions annually due to write-offs, along with the expensive labor involved in investigating and contesting these denials while addressing patient inquiries. Conversely, payers also face similar challenges in the claims management process, as they incur expenses from covering unnecessary medical procedures and treatments, as well as the resources dedicated to handling denial appeals, all of which do not contribute to better patient outcomes. Additionally, patients may suffer from excessive copays and other out-of-pocket expenses, coupled with a frustrating healthcare experience due to charges and services that are not warranted. To combat these issues, the ABN Assistant™ from Vālenz® Assurance equips providers with essential prior authorization tools to confirm medical necessity, generate Medicare-compliant Advanced Beneficiary Notices (ABNs) that include estimated costs, and effectively prevent over 90 percent of medical necessity denials by ensuring that the necessity is validated before any care is administered to the patient. By utilizing this system, providers can enhance their financial stability while improving patient satisfaction and care efficiency.

Carevive provides a cancer care management platform that is integrated with electronic health records (EHR) to improve patient outcomes across the entire cancer treatment process. This innovative platform streamlines treatment planning by gathering patient preferences, evaluating interests in clinical trials, and tackling both physical and psychosocial challenges to enhance decision-making processes. During the active treatment phase, Carevive supports remote monitoring of symptoms through electronic patient-reported outcomes (ePROs), offering personalized symptom management plans and evidence-based pathways that aim to elevate quality of life and minimize hospital admissions. After treatment concludes, the platform continues to monitor patient-reported late effects and organizes essential care, which includes diagnostic assessments to identify new or recurring cancers. Furthermore, Carevive's analytics provide insights into aggregated patient experience data, aiding in ongoing quality enhancement and contributing to practical research in oncology. This comprehensive approach ensures that patients receive holistic support throughout their cancer journey, ultimately leading to better health outcomes.